In head and neck squamous cell carcinoma, RIPK1 downregulation increased the risk of metastasis through inhibition of NF-κB-pathway-dependent TLR3 receptor and by promoting apoptosis over necrosis [51]. Here, NFKB1 is linked to head and neck squamous cell carcinoma.